Is high titre ANA specific for connective tissue disease ?
J.H. Vaile, L. Dyke, R. Kherani, C. Johnston, T. Higgins1, A.S. Russell
Division of Rheumatology, University of Alberta; 1Dynacare Kasper Medical Laboratories, Edmonton, Alberta, Canada
ABSTRACT
Objective
A positive antinuclear antibody (ANA), while sensitive, is
not specific for systemic lupus erythematosus or connective
tissue diseases (CTD). The purpose of the present study was to
review those sera with a high titre (³ 4 dilutions above
screening) ANA and determine from a review of the charts if these
higher titres offered a satisfactory specificity for CTD.
Methods
All FANA testing in this region is carried out in one of
two related laboratories. We reviewed the medical records of
patients who had a positive ANA at a titre 4 dilutions above
screenmg at this city-wide laboratory over a 6-month period to
determine whether this titre (high titre) may offer
relative diagnostic certainty. Antibodies to extractable nuclear
antigens (ENA) and native DNA were also obtained.
Results
422 ANA results were positive at high titre. The medical
record was available for review in 320 patients, of whom 238
(75%) were seen by a specialist physician, almost always
including a rheumatologist. Our review determined that 35% had a
diagnosis of connective tissue disease, 21% had a diagnosis of a
possible/probable inflammatory disease, 16% had an alternative
specific diagnosis provided, and in 29% no final disease specific
diagnosis was recorded but CTD was not suggested to us or the
specialist by the data available. One or more anti-ENA antibodies
and/or anti-DNA were positive in 69 (22%) and 8% of the sera
tested respectively.
Conclusion
While long term follow-up is still required, a significant
proportion of patients with high titre ANA have no CTD at the
time of testing. Setting a higher cutoff for reporting of ANA may
not increase specificity sufficiently to make it a useful
alternative or addition to reporting a positive or negative value
at screening titre alone.
Key words
ANA, titre, specificity.
Please address reprints requests to: Dr. A.S. Russell, 562 Heritage Medical Research Centre,
University of Alberta, Edmonton, Alberta Canada T6G 2S2.
E-mail: asr@gpu.srv.ualberta.ca
Clin Exp Rheumatol 2000; 18:
433-438.
© Copyright Clinical and Experimental
Rheumatology 2000.